ID1 and lymphoma: The contribution of EPCs to tumor vasculogenesis was demonstrated using angiogenesis-defective Id mutant (Id1+/−Id3−/−) and wild-type mice inoculated with human lymphoma and Lewis lung carcinoma (LLC) cells.